MA54534A - Antagonistes - Google Patents

Antagonistes

Info

Publication number
MA54534A
MA54534A MA054534A MA54534A MA54534A MA 54534 A MA54534 A MA 54534A MA 054534 A MA054534 A MA 054534A MA 54534 A MA54534 A MA 54534A MA 54534 A MA54534 A MA 54534A
Authority
MA
Morocco
Prior art keywords
antagonists
Prior art date
Application number
MA054534A
Other languages
English (en)
Inventor
Allan Bradley
Li-Tzu Chen
Yen-Ju Chen
Yu-Hui Huang
E-Chiang Lee
Qi Liang
Li-Ying Liou
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Publication of MA54534A publication Critical patent/MA54534A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA054534A 2018-12-19 2019-12-18 Antagonistes MA54534A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1820687.0A GB201820687D0 (en) 2018-12-19 2018-12-19 Antagonists

Publications (1)

Publication Number Publication Date
MA54534A true MA54534A (fr) 2022-03-30

Family

ID=65147244

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054534A MA54534A (fr) 2018-12-19 2019-12-18 Antagonistes

Country Status (16)

Country Link
US (1) US20220049017A1 (fr)
EP (1) EP3897830A2 (fr)
JP (1) JP7522113B2 (fr)
KR (1) KR20210105396A (fr)
CN (1) CN113453756B (fr)
AU (1) AU2019411526A1 (fr)
BR (1) BR112021011886A2 (fr)
CA (1) CA3122655A1 (fr)
CO (1) CO2021007653A2 (fr)
GB (1) GB201820687D0 (fr)
IL (1) IL283413A (fr)
MA (1) MA54534A (fr)
MX (1) MX2021007448A (fr)
SG (1) SG11202105784WA (fr)
TW (1) TW202039565A (fr)
WO (1) WO2020128467A2 (fr)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731568A (en) 1995-10-13 1998-03-24 Arctic Fox, Inc. Battery heating device and method
ES2246069T3 (es) 1997-05-02 2006-02-01 Genentech, Inc. Procedimiento de preparacion de anticuerpos multiespecificos que tienen componentes comunes y multimericos.
CA2603408C (fr) 2005-03-31 2018-08-21 Chugai Seiyaku Kabushiki Kaisha Methodes de production de polypeptides par regulation de l'association de polypeptides
DK1999154T3 (da) 2006-03-24 2012-12-03 Merck Patent Gmbh Fremstillede heterodimere proteindomæner
AT503889B1 (de) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F Multivalente immunglobuline
JOP20080381B1 (ar) 2007-08-23 2023-03-28 Amgen Inc بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
KR102010827B1 (ko) 2009-06-26 2019-08-14 리제너론 파마슈티칼스 인코포레이티드 천연 면역글로불린 포맷을 가지는 용이하게 분리된 이중특이성 항체
EP4215043A1 (fr) 2009-07-08 2023-07-26 Kymab Limited Modèles d'animaux et molécules thérapeutiques
US9527926B2 (en) 2010-05-14 2016-12-27 Rinat Neuroscience Corp. Heterodimeric proteins and methods for producing and purifying them
EP2650016A1 (fr) * 2011-01-28 2013-10-16 Sanofi Anticorps humains anti-PSCK9 pour une utilisation dans des procédés de traitement basés sur des régimes de dosage particuliers (11565)
KR102545770B1 (ko) 2012-04-20 2023-06-21 메뤼스 엔.페. Ig-유사 분자의 제조방법 및 제조수단
JP6267792B2 (ja) * 2013-06-28 2018-01-24 アムジエン・インコーポレーテツド ホモ接合性家族性高コレステロール血症の治療方法
WO2015092394A1 (fr) 2013-12-17 2015-06-25 Kymab Limited Anticorps destinés à être utilisés pour traiter des états associés à des variants spécifiques de pcsk9 chez des populations de patients spécifiques
CN106062004A (zh) * 2013-12-17 2016-10-26 科马布有限公司 人靶标
US9017678B1 (en) * 2014-07-15 2015-04-28 Kymab Limited Method of treating rheumatoid arthritis using antibody to IL6R
US10519251B2 (en) 2013-12-30 2019-12-31 Epimab Biotherapeutics, Inc. Fabs-in-tandem immunoglobulin and uses thereof
CN106589127A (zh) * 2015-10-16 2017-04-26 钜川生物医药 一种pcsk9抗体及其制备方法和应用

Also Published As

Publication number Publication date
CN113453756B (zh) 2024-08-02
EP3897830A2 (fr) 2021-10-27
GB201820687D0 (en) 2019-01-30
SG11202105784WA (en) 2021-07-29
JP7522113B2 (ja) 2024-07-24
MX2021007448A (es) 2021-12-10
JP2022514703A (ja) 2022-02-14
US20220049017A1 (en) 2022-02-17
WO2020128467A2 (fr) 2020-06-25
WO2020128467A3 (fr) 2020-07-23
CA3122655A1 (fr) 2020-06-25
TW202039565A (zh) 2020-11-01
AU2019411526A1 (en) 2021-06-17
CN113453756A (zh) 2021-09-28
KR20210105396A (ko) 2021-08-26
CO2021007653A2 (es) 2021-09-30
IL283413A (en) 2021-07-29
BR112021011886A2 (pt) 2021-09-08

Similar Documents

Publication Publication Date Title
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
DK3752258T3 (da) Trampolin
MA54534A (fr) Antagonistes
DK3587968T3 (da) Fluidsystem
MA49925A (fr) Claie
DE112019000442A5 (de) Ringtilgereinrichtung
NO20181678A1 (no) Rissanviser
UA39236S (uk) Кріплення-дюбель
UA39237S (uk) Кріплення-дюбель
UA39238S (uk) Кріплення-дюбель
UA39239S (uk) Кріплення-дюбель
UA39241S (uk) Кріплення-дюбель
UA39242S (uk) Кріплення-дюбель
UA39231S (uk) Мотоблок
JP1628556S (ja) たい焼
JP1628555S (ja) たい焼
UA39128S (uk) Сівалка зернова сз-3
ES1218724Y (es) Terrario
ES1224156Y (es) Ecobolsera
UA38606S (uk) Електролобзик
UA38585S (uk) Електролобзик
UA38632S (uk) Електролобзик
UA38581S (uk) Термокухоль
UA38582S (uk) Термокухоль
UA38633S (uk) Електролобзик